Federal Centers for the Control and Prevention of Diseases (CKPZ) The United States recommended the use of booster doses of vaccine from COVID-19 Pfizer and Biontech companies among adolescents aged 12 to 15 years. This is stated in the CCPZ statement, reports TASS.
“It is extremely necessary to ensure the protection of our children and adolescents from the infection of COVID-19 and the severe effects of the disease,” the head of the head of the CCPZ Rochel Valenski. He added that now the center recommends that all adolescents aged 12 to 17 years old have a booster dose of the vaccine five months after the initial vaccination.
Earlier scientists of the University of Ohio (USA) found out that the booster doses of the MODERNA and PFizer / Biontech vaccine are capable of protecting against an oomicron-option of coronavirus, which reduces the effectiveness of the first two doses. It turned out that the Omicron option demonstrates resistance to neutralizing antibodies, which is 22.9 times higher than the resistance of the original strain D614G.